Cantuzumab ravtansine [CAS 868747-45-9]

Cantuzumab ravtansine (IMGN242; huC242-DM4), an ADC, is a humanized monoclonal antibody, huC242, covalently linked via a disulfide bond to DM4. Cantuzumab ravtansine has broad antitumor efficacy against a range of CanAg-positive human tumor xenografts[1][2].

[868747-45-9]

[Cantuzumabravtansine]

Antibody-Drug Conjugates (ADCs) ; Microtubule/Tubulin

98.71

10 mM in DMSO

-80°C, protect from light

Dry Ice